OTC · Financial Statements
Medivolve Inc. (MEDVF) Financial Statements
$0.00
OTC: MEDVF
Market Cap $2702
Overview Financials Dividend
Medivolve Inc. most recently reported annual revenue of $1.0M, a net loss of $16.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023
Revenue $0 $11.0M $87.0M $1.0M $1.0M Operating Profit $-3.0M $-24.0M $0 $-14.0M $-4.0M Net Profit $-3.0M $-38.0M $-7.0M $-18.0M $-16.0M EPS $-1.19 $-5.66 $-0.34 $-0.68 $-0.61 Op Margin 1694.7% -230.8% -0.1% -1044.1% -521.5%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023
Total Assets $2.0M $19.0M $59.0M $19.0M $2.0M Total Liabilities $0 $29.0M $41.0M $18.0M $18.0M Cash $0 $1.0M $0 $4.0M $1.0M Borrowings $0 $20.0M $2.0M $2.0M $2.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023
Operating Cash Flow $-4.0M $-11.0M $-9.0M $6.0M $-3.0M Investing Cash Flow $-1.0M $-9.0M $-1.0M $0 $0 Financing Cash Flow $0 $0 $0 $-1.0M $-1.0M Net Cash Flow $-4.0M $1.0M $-1.0M $4.0M $-3.0M Free Cash Flow $-4.0M $-15.0M $-9.0M $6.0M $-3.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.61 FCF Yield -386.51% Quick Ratio 0.08 Interest Coverage — Return 1Y -95.00% Return 3Y -99.72% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .